Literature DB >> 22072749

Evidence against extracellular exposure of a highly immunogenic region in the C-terminal domain of the simian immunodeficiency virus gp41 transmembrane protein.

Thomas S Postler1, José M Martinez-Navio, Eloísa Yuste, Ronald C Desrosiers.   

Abstract

The generally accepted model for human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein topology includes a single membrane-spanning domain. An alternate model has been proposed which features multiple membrane-spanning domains. Consistent with the alternate model, a high percentage of HIV-1-infected individuals produce unusually robust antibody responses to a region of envelope, the so-called "Kennedy epitope," that in the conventional model should be in the cytoplasm. Here we show analogous, robust antibody responses in simian immunodeficiency virus SIVmac239-infected rhesus macaques to a region of SIVmac239 envelope located in the C-terminal domain, which in the conventional model should be inside the cell. Sera from SIV-infected rhesus macaques consistently reacted with overlapping oligopeptides corresponding to a region located within the cytoplasmic domain of gp41 by the generally accepted model, at intensities comparable to those observed for immunodominant areas of the surface component gp120. Rabbit serum raised against this highly immunogenic region (HIR) reacted with SIV envelope in cell surface-staining experiments, as did monoclonal anti-HIR antibodies isolated from an SIVmac239-infected rhesus macaque. However, control experiments demonstrated that this surface staining could be explained in whole or in part by the release of envelope protein from expressing cells into the supernatant and the subsequent attachment to the surfaces of cells in the culture. Serum and monoclonal antibodies directed against the HIR failed to neutralize even the highly neutralization-sensitive strain SIVmac316. Furthermore, a potential N-linked glycosylation site located close to the HIR and postulated to be outside the cell in the alternate model was not glycosylated. An artificially introduced glycosylation site within the HIR was also not utilized for glycosylation. Together, these data support the conventional model of SIV envelope as a type Ia transmembrane protein with a single membrane-spanning domain and without any extracellular loops.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22072749      PMCID: PMC3255797          DOI: 10.1128/JVI.06463-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  64 in total

1.  Snorkeling preferences foster an amino acid composition bias in transmembrane helices.

Authors:  Aaron K Chamberlain; Yohan Lee; Sanguk Kim; James U Bowie
Journal:  J Mol Biol       Date:  2004-05-28       Impact factor: 5.469

2.  Immunogenic and antigenic dominance of a nonneutralizing epitope over a highly conserved neutralizing epitope in the gp41 envelope glycoprotein of human immunodeficiency virus type 1: its deletion leads to a strong neutralizing response.

Authors:  S M Cleveland; E Buratti; T D Jones; P North; F Baralle; L McLain; T McInerney; Z Durrani; N J Dimmock
Journal:  Virology       Date:  2000-01-05       Impact factor: 3.616

3.  The simian immunodeficiency virus envelope glycoprotein contains multiple signals that regulate its cell surface expression and endocytosis.

Authors:  K Bowers; A Pelchen-Matthews; S Höning; P J Vance; L Creary; B S Haggarty; J Romano; W Ballensiefen; J A Hoxie; M Marsh
Journal:  Traffic       Date:  2000-08       Impact factor: 6.215

4.  Mutations within the putative membrane-spanning domain of the simian immunodeficiency virus transmembrane glycoprotein define the minimal requirements for fusion, incorporation, and infectivity.

Authors:  J T West; P B Johnston; S R Dubay; E Hunter
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

5.  The immunodominance of epitopes within the transmembrane protein (gp41) of human immunodeficiency virus type 1 may be determined by the host's previous exposure to similar epitopes on unrelated antigens.

Authors:  D Davis; B Chaudhri; D M Stephens; C A Carne; C Willers; P J Lachmann
Journal:  J Gen Virol       Date:  1990-09       Impact factor: 3.891

6.  A region of the C-terminal tail of the gp41 envelope glycoprotein of human immunodeficiency virus type 1 contains a neutralizing epitope: evidence for its exposure on the surface of the virion.

Authors:  S Matthew Cleveland; Lesley McLain; Linda Cheung; Tim D Jones; Mark Hollier; Nigel J Dimmock
Journal:  J Gen Virol       Date:  2003-03       Impact factor: 3.891

7.  Human immunodeficiency virus type 1 envelope glycoproteins that lack cytoplasmic domain cysteines: impact on association with membrane lipid rafts and incorporation onto budding virus particles.

Authors:  Jayanta Bhattacharya; Paul J Peters; Paul R Clapham
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

8.  Assorted mutations in the envelope gene of simian immunodeficiency virus lead to loss of neutralization resistance against antibodies representing a broad spectrum of specificities.

Authors:  Welkin E Johnson; Hannah Sanford; Linda Schwall; Dennis R Burton; Paul W H I Parren; James E Robinson; Ronald C Desrosiers
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

9.  A novel monoclonal antibody specific to the C-terminal tail of the gp41 envelope transmembrane protein of human immunodeficiency virus type 1 that preferentially neutralizes virus after it has attached to the target cell and inhibits the production of infectious progeny.

Authors:  Steven A Reading; Caroline J Heap; Nigel J Dimmock
Journal:  Virology       Date:  2003-10-25       Impact factor: 3.616

Review 10.  The antiviral activity of antibodies in vitro and in vivo.

Authors:  P W Parren; D R Burton
Journal:  Adv Immunol       Date:  2001       Impact factor: 3.543

View more
  16 in total

1.  Dense Array of Spikes on HIV-1 Virion Particles.

Authors:  Armando Stano; Daniel P Leaman; Arthur S Kim; Lei Zhang; Ludovic Autin; Jidnyasa Ingale; Syna K Gift; Jared Truong; Richard T Wyatt; Arthur J Olson; Michael B Zwick
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

2.  Distinct functions for the membrane-proximal ectodomain region (MPER) of HIV-1 gp41 in cell-free and cell-cell viral transmission and cell-cell fusion.

Authors:  Vani G S Narasimhulu; Anna K Bellamy-McIntyre; Annamarie E Laumaea; Chan-Sien Lay; David N Harrison; Hannah A D King; Heidi E Drummer; Pantelis Poumbourios
Journal:  J Biol Chem       Date:  2018-03-01       Impact factor: 5.157

3.  Neutralizing capacity of monoclonal antibodies that recognize peptide sequences underlying the carbohydrates on gp41 of simian immunodeficiency virus.

Authors:  José M Martinez-Navio; Ronald C Desrosiers
Journal:  J Virol       Date:  2012-09-19       Impact factor: 5.103

Review 4.  The cytoplasmic tail of retroviral envelope glycoproteins.

Authors:  Philip R Tedbury; Eric O Freed
Journal:  Prog Mol Biol Transl Sci       Date:  2014-12-01       Impact factor: 3.622

Review 5.  The tale of the long tail: the cytoplasmic domain of HIV-1 gp41.

Authors:  Thomas S Postler; Ronald C Desrosiers
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

Review 6.  The frantic play of the concealed HIV envelope cytoplasmic tail.

Authors:  Eveline Santos da Silva; Martin Mulinge; Danielle Perez Bercoff
Journal:  Retrovirology       Date:  2013-05-24       Impact factor: 4.602

7.  The Tat inhibitor didehydro-cortistatin A suppresses SIV replication and reactivation.

Authors:  Sonia Mediouni; Cari F Kessing; Joseph A Jablonski; Suzie Thenin-Houssier; Mark Clementz; Melia D Kovach; Guillaume Mousseau; Ian Mitchelle S de Vera; Chuan Li; Douglas J Kojetin; David T Evans; Susana T Valente
Journal:  FASEB J       Date:  2019-04-25       Impact factor: 5.834

Review 8.  C-terminal tail of human immunodeficiency virus gp41: functionally rich and structurally enigmatic.

Authors:  Jonathan D Steckbeck; Anne-Sophie Kuhlmann; Ronald C Montelaro
Journal:  J Gen Virol       Date:  2012-10-17       Impact factor: 3.891

9.  Biological and biochemical characterization of HIV-1 Gag/dgp41 virus-like particles expressed in Nicotiana benthamiana.

Authors:  Sarah A Kessans; Mark D Linhart; Nobuyuki Matoba; Tsafrir Mor
Journal:  Plant Biotechnol J       Date:  2013-03-19       Impact factor: 9.803

10.  Detailed topology mapping reveals substantial exposure of the "cytoplasmic" C-terminal tail (CTT) sequences in HIV-1 Env proteins at the cell surface.

Authors:  Jonathan D Steckbeck; Chengqun Sun; Timothy J Sturgeon; Ronald C Montelaro
Journal:  PLoS One       Date:  2013-05-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.